PackGene Biotech INC    

https://www.packgene.com/

Welcome to 2023 ASGCT! Let's make Gene Therapy Affordable!

PackGene Biotech excels as a leader in Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, focusing on adeno-associated virus (AAV), mRNA, plasmid DNA, and lentiviral vector (LVV) solutions. Catering to early-stage drug discovery, preclinical development, and cell and gene therapy trials, we offer cost-effective, reliable, and scalable production. Our π-Alpha 293 AAV High-yield Platform marks a significant leap in AAV production, increasing yields by up to tenfold and supporting large-scale AAV batches up to 1E+17vg, meeting most commercial and clinical project needs. We also provide scalable, custom plasmid DNA solutions for various project sizes, encompassing end-to-end design, production, and manufacturing. Our GMP plasmid Manufacturing Platform can accommodate production scales from 5L to 200L. Our services extend to comprehensive process development, analytical development, and cell banking support for AAV, LVV, and plasmid projects. Additionally, we specialize in mRNA and LNP solutions, supporting the full spectrum of drug and vaccine development from research to GMP production. Committed to fostering innovation in biotechnology and healthcare, PackGene offers advanced solutions tailored to the evolving demands of the industry.

Brands: We are top AAV vector CRO & CDMO. Our proprietary π-Alpha™ 293 AAV High-yield Platform can increase AAV production up to 10x and a capacity of 1E+17vg virus particles per batch from RUO to GMP.

 Press Releases

• PackGene AAV cGMP Manufacturing Service (Mar 12, 2024)
  
  PackGene facilitates GMP-grade AAV production for gene therapy, covering clinical trials to commercial scale.

• Welcome to PackGene--Your Gene Therapy Partner at Booth #1634 (Apr 25, 2024)
  ASGCT 2024 event-only deals:
  -Free Cloning with piVector Designer
  -20% off our AAV (NHP grade) services
  -20% off LVV packaging services
  -Special BOGO on all off-the-shelf mRNA
   

• A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefinin (Apr 07, 2025)
  GC4K announced the collaboration with PackGene Biotech and the Belfer Gene Therapy Core Facility at Weill Cornell Medicine to a new therapy for an ultra-rare disease SPG56. 

 Products